TABLE 2.
Distribution of pre- and post-transplant cardiovascular risk factors among sub-cohort (n=509*).
Trait, n (%) | Pre-transplant | 1-yr post-transplant | Last follow-up | |||
---|---|---|---|---|---|---|
History of tobacco use† | 171 | (33.8) | - | - | ||
Current user | 49 | (9.7) | - | - | ||
Body mass index‡, kg/m2 | ||||||
Underweight, <18.5 | 11 | (2.2) | 21 | (4.3) | - | |
Normal, 18.5–24 | 206 | (41.4) | 224 | (46.2) | - | |
Overweight, 25–29 | 167 | (33.5) | 138 | (28.5) | - | |
Obese, ≥30 | 114 | (22.9) | 102 | (21.0) | - | |
Hypertension treatment | 34 | (6.7) | 98 | (19.6) | 119 | (23.9) |
On treatment at prior time point, still on | - | 28 | (5.6) | 63 | (12.7) | |
Off treatment at prior time point, now on | - | 70 | (14.0) | 56 | (11.2) | |
On treatment at prior time point, now off | - | 6 | (1.2) | 34 | (6.8) | |
Dyslipidemia treatment | 15 | (3.0) | 14 | (2.8) | 79 | (15.8) |
On treatment at prior time point, still on | - | 7 | (1.4) | 13 | (2.6) | |
Off treatment at prior time point, now on | - | 7 | (1.4) | 64 | (12.8) | |
On treatment at prior time point, now off | - | 8 | (1.6) | 1 | (0.2) | |
Diabetes treatment | 21 | (4.1) | 65 | (12.9) | 54 | (10.7) |
On treatment at prior time point, still on | - | 21 | (4.2) | 31 | (6.2) | |
Off treatment at prior time point, now on | - | 44 | (8.7) | 23 | (4.6) | |
On treatment at prior time point, now off | - | 0 | 34 | (6.7) |
Percentages based on those with data among the sub-cohort (depending on the risk factor and time point, n=498 to 509).
Only assessed pre-transplant.
Limited to those age ≥2 years. Values for survivors ages 2–20 years based on equivalent age- and sex-specific percentiles. Only assessed pre-transplant and 1-yr post-transplant.